Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials
Crossref DOI link: https://doi.org/10.1007/s40262-015-0305-z
Published Online: 2015-08-05
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Minocha, Mukul
Tran, Jonathan Q.
Sheridan, James P.
Othman, Ahmed A.
Funding for this research was provided by:
AbbVie
Text and Data Mining valid from 2015-08-05